From Biomarkers to Companion Diagnostics: Transforming the Therapeutic Landscape of Non-Small Cell Lung Cancer Case Study

This case study offers insights from multiple success stories of partnering with leading pharmaceutical companies to investigate and validate biomarkers, manage clinical trials and launch companion diagnostic assays for NSCLC.